Cite
HARVARD Citation
Alsina, L. et al. (2017). Surveillance study on the tolerability and safety of Flebogamma® DIF (10% and 5% intravenous immunoglobulin) in adult and pediatric patients. Pharmacology research & perspectives. 5 (5), p. n/a. [Online].